Influence of Xianglingwan on dysmenorrhea and serum CA125 in treating patients with endometriosis.
- Author:
Chun-Bo YANG
1
;
Yi CHEN
;
Hang-Mei JIN
;
Wei-Wen YING
Author Information
- Publication Type:Journal Article
- MeSH: Adult; CA-125 Antigen; blood; Drugs, Chinese Herbal; pharmacology; Dysmenorrhea; blood; drug therapy; Endometriosis; blood; drug therapy; Female; Humans
- From: China Journal of Chinese Materia Medica 2008;33(5):567-569
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the influence of Xianglingwan on dysmenorrhea and serum CA125 in treating patients with endometriosis.
METHODA total of 54 patients with endometriosis and without medical complications were random selected. Xianglingwan was administered from the fifth day of the menstrual cycle for 3 weeks every month as a therapeutic course, and three months for a therapeutic period. Pelvic type B ultrasonograph and blood CA125 were detected before and after treatment. Visual analogue scale was admitted to evaluate the dysmenorrhea.
RESULTThe serum CA125 reduced obviously after therapy. There was a significant difference between them (P < 0.01). The symptom of dysmenorrhea also reduced obviously after treatment. There was a significant difference between them (P < 0.05).
CONCLUSIONXianglingwan can treat edometriosis effectively, and has less adverse reactions, it can also reduce the symptom of dysmenorrheal and the serum CA125.
